PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions

被引：0
|
作者：
A. Afshar-Oromieh
A. Malcher
M. Eder
M. Eisenhut
H. G. Linhart
B. A. Hadaschik
T. Holland-Letz
F. L. Giesel
C. Kratochwil
S. Haufe
U. Haberkorn
C. M. Zechmann
机构：
[1] University Hospital of Heidelberg,Department of Nuclear Medicine
[2] German Cancer Research Center,Department of Radiopharmaceutical Chemistry
[3] National Center for Tumor Diseases (NCT)/DKFZ,Department of Urology
[4] University Hospital of Heidelberg,Department of Biostatistics
[5] German Cancer Research Center,Clinical Cooperation Unit Nuclear Medicine
[6] German Cancer Research Centre,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2013年 / 40卷
关键词：
Prostate cancer; PET/CT; Positron emission tomography; PSMA; Prostate-specific membrane antigen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：486 / 495
页数：9
相关论文
共 50 条
  • [41] Preparation and biodistribution assessment of 68Ga-DKFZ-PSMA-617 for PET prostate cancer imaging
    Mehdi Sharifi
    Hassan Yousefnia
    Samaneh Zolghadri
    Ali Bahrami-Samani
    Mojdeh Naderi
    Amir Reza Jalilian
    Parham Geramifar
    Davood Beiki
    Nuclear Science and Techniques, 2016, 27
  • [42] Effect of furosemide on the bladder quantitative parameters in patients undergoing Gallium-68[68Ga] Ga-PSMA-11 PET/CT for diagnosis of prostate cancer
    Valenzuela, D.
    Tormo-Ratera, M.
    Papa, N.
    Eapen, R.
    Emmett, L.
    Moon, D.
    Murphy, D.
    Ayati, N.
    Hofman, M.
    Buteau, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S544 - S544
  • [43] Cyclotron produced 68Ga for PET imaging of prostate cancer
    Ahad, Afruja
    Easwaroorthy, Balu
    Zhang, Hanwen
    Pillarsetty, NagaVaraKishore
    Alidindi, Teja
    Punzalan, Blesida
    Colina, Angel
    Osborne, Joseph
    Larson, Steven
    Vallabhajosula, Shankar
    Weber, Wolfgang
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [44] Predictor of 68Ga PSMA PET/CT positivity in patients with prostate cancer
    Soydal, Cigdem
    Urun, Yuksel
    Suer, Evren
    Nak, Demet
    Ozkan, Elgin
    Kucuk, Nuriye O.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 64 (02): : 226 - 230
  • [45] A prospective comparative study of [68Ga]Ga-RM26 and [68Ga]Ga-PSMA-617 PET/CT imaging in suspicious prostate cancer
    Gao, Xiaomei
    Tang, Yongxiang
    Chen, Minfeng
    Li, Jian
    Yin, Hongling
    Gan, Yu
    Zu, Xiongbin
    Cai, Yi
    Hu, Shuo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (07) : 2177 - 2187
  • [46] A prospective comparative study of [68Ga]Ga-RM26 and [68Ga]Ga-PSMA-617 PET/CT imaging in suspicious prostate cancer
    Xiaomei Gao
    Yongxiang Tang
    Minfeng Chen
    Jian Li
    Hongling Yin
    Yu Gan
    Xiongbin Zu
    Yi Cai
    Shuo Hu
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2177 - 2187
  • [47] Biodistribution and radiation dosimetry of 68Ga-PSMA HBED CC—a PSMA specific probe for PET imaging of prostate cancer
    Christian H. Pfob
    Sibylle Ziegler
    Frank Philipp Graner
    Markus Köhner
    Sylvia Schachoff
    Birgit Blechert
    Hans-Jürgen Wester
    Klemens Scheidhauer
    Markus Schwaiger
    Tobias Maurer
    Matthias Eiber
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1962 - 1970
  • [48] [68Ga]PSMA-11 for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer
    Clore, Jessica
    Scott, Peter J. H.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2024,
  • [49] Selection of Optimal Quantification Metric in Static Prostate Cancer Imaging with the PSMA-targeted [68Ga]Ga-PSMA-11 and [68Ga]Ga-P16093 PET Radiopharmaceuticals
    Territo, Wendy
    Hutchins, Gary
    Clint, Bahler
    Tann, Mark
    Collins, Katrina
    Mathias, Carla
    Alexoff, David
    Kung, Hank
    Green, Mark
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [50] Comparison of PET imaging with a 68Ga-labelled PSMA ligand versus 18F-choline PET/CT for the diagnosis of Prostate Cancer & Radioprotection for involved personnel
    Zeinab Khansa
    Mohamad B. Haidar
    Nemer Neaimeh
    Mahmoud Korek
    Health and Technology, 2019, 9 : 607 - 613
12345